Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
David J. Straus
Research Funding - Merck
Paul A. Hamlin
Research Funding - Merck
Matthew J. Matasar
No relevant relationships to disclose
Maria Lia Palomba
No relevant relationships to disclose
Pamela Drullinsky
No relevant relationships to disclose
Andrew David Zelenetz
No relevant relationships to disclose
John F. Gerecitano
No relevant relationships to disclose
Ariela Noy
No relevant relationships to disclose
Audrey M. Hamilton
No relevant relationships to disclose
Brett Wegner
Research Funding - Merck
Zhigang Zhang
Research Funding - Merck
Rebecca L. Elstrom
Research Funding - Merck
David Cella
Research Funding - Merck